Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2016 (2016), Article ID 2543156, 7 pages
http://dx.doi.org/10.1155/2016/2543156
Research Article

Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India

1Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi 110029, India
2Department of Transfusion Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareilly Road, Lucknow 226014, India
3Hemogenomics Pvt. Ltd., New Delhi 110044, India

Received 26 September 2015; Revised 18 December 2015; Accepted 29 December 2015

Academic Editor: Rino Ragno

Copyright © 2016 Rahul Chaurasia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. S. Bharucha, “Safe blood transfusion practices,” The Indian Journal of Pediatrics, vol. 68, no. 2, pp. 127–131, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. B. R. Jackson, M. P. Busch, S. L. Stramer, and J. P. AuBuchon, “The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations,” Transfusion, vol. 43, no. 6, pp. 721–729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. The Kirby Institute, The University of New South Wales, and Australian Red Cross Blood Service, Transfusion-Transmissible Infections in Australia: 2014 Surveillance Report, The Kirby Institute, The University of New South Wales and Australian Red Cross Blood Service, 2014.
  4. D. Arora, B. Arora, and A. Khetarpal, “Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana,” Indian Journal of Pathology and Microbiology, vol. 53, no. 2, pp. 308–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Chandra, S. N. F. Rizvi, and D. Agarwal, “Decreasing prevalence of transfusion transmitted infection in Indian scenario,” The Scientific World Journal, vol. 2014, Article ID 173939, 4 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Chatterjee, P. Coshic, M. Borgohain et al., “Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital,” National Medical Journal of India, vol. 25, no. 4, pp. 207–209, 2012. View at Google Scholar · View at Scopus
  7. P. Kaur and S. Basu, “Transfusion-transmitted infections: existing and emerging pathogens,” Journal of Postgraduate Medicine, vol. 51, no. 2, pp. 146–151, 2005. View at Google Scholar · View at Scopus
  8. M. Meena, T. Jindal, and A. Hazarika, “Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study,” Transfusion, vol. 51, no. 1, pp. 198–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Pallavi, C. K. Ganesh, K. Jayashree, and G. V. Manjunath, “Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study,” Indian Journal of Hematology and Blood Transfusion, vol. 27, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. N. Makroo, N. Choudhury, L. Jagannathan et al., “Multicenter evaluation of individual donor Nucleic Acid Testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors,” Indian Journal of Medical Research, vol. 127, no. 2, pp. 140–147, 2008. View at Google Scholar · View at Scopus
  11. Gen-Probe Incorporated, “Procleix ultrio assay,” 502623 rev. A, Genetic Center Drive, San Diego, Calif, USA.
  12. Gen-Probe Incorporated, “Procleix ultrio elite assay,” 503049en rev. A, Genetic Center Drive, San Diego, Calif, USA.
  13. COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, Doc Rev 1.0, Roche Diagnostics, Indianapolis, Ind, USA, 2007.
  14. Abbott RealTime HBV, 51-602150/r1, Abbott Molecular, Des Plaines, Ill, USA.
  15. A. Assal, V. Barlet, M. Deschaseaux et al., “Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: procleix tigris and cobas s 201,” Transfusion, vol. 49, no. 2, pp. 289–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Grabarczyk, H. Van Drimmelen, A. Kopacz et al., “Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 in blood donors,” Transfusion, vol. 53, no. 10, pp. 2512–2524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-P. Allain, “Occult hepatitis B virus infection: implications in transfusion,” Vox Sanguinis, vol. 86, no. 2, pp. 83–91, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. E. L. Snyder and R. Y. Dodd, “Reducing the risk of blood transfusion,” Hematology, no. 1, pp. 433–442, 2001. View at Publisher · View at Google Scholar
  19. R. Hans and N. Marwaha, “Nucleic acid testing-benefits and constraints,” Asian Journal of Transfusion Science, vol. 8, no. 1, pp. 2–3, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Agarwal, K. Chatterjee, P. Coshic, and M. Borgohain, “Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India,” Transfusion and Apheresis Science, vol. 49, no. 3, pp. 482–484, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Chaurasia, S. Zaman, B. Das, and K. Chatterjee, “Screening donated blood for transfusion transmitted infections by serology along with NAT and response rate to notification of reactive results: an Indian experience,” Journal of Blood Transfusion, vol. 2014, Article ID 412105, 6 pages, 2014. View at Publisher · View at Google Scholar
  22. W.-C. Tsoi, N. Lelie, and C.-K. Lin, “Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay,” Transfusion, vol. 53, no. 10, pp. 2477–2488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Vermeulen, C. Dickens, N. Lelie et al., “Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk,” Transfusion, vol. 52, no. 4, pp. 880–892, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Datta, “An overview of molecular epidemiology of Hepatitis B Virus (HBV) in India,” Virology Journal, vol. 5, article 156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Doda, S. Arora, and T. Kirtania, “Serological characterization of occult hepatitis B virus infection among blood donors in India,” Transfusion and Apheresis Science, vol. 51, no. 2, pp. 162–167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Yugi, M. Mizui, J. Tanaka, and H. Yoshizawa, “Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing—Japanese experience,” Journal of Clinical Virology, vol. 36, supplement 1, pp. S56–S64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T.-H. Su, P.-J. Chen, T.-C. Chen et al., “The clinical significance of occult hepatitis B transfusion in Taiwan—a look-back study,” Transfusion Medicine, vol. 21, no. 1, pp. 33–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. R. N. Makroo, M. Chowdhry, A. Bhatia, B. Arora, and N. L. Rosamma, “Hepatitis B core antibody testing in Indian blood donors: a double-edged sword!,” Asian Journal of Transfusion Science, vol. 6, no. 1, pp. 10–13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. K. Dhawan, N. Marwaha, R. R. Sharma et al., “Anti-HBc screening in Indian blood donors: still an unresolved issue,” World Journal of Gastroenterology, vol. 14, no. 34, pp. 5327–5330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Sundaravaradan, S. R. Das, R. Ramakrishnan et al., “Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages,” Virology Journal, vol. 4, article 126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Kannangai, R. V. Shaji, S. Ramalingam et al., “HIV-2 subtype circulating in India (south),” Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 2, pp. 219–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. WHO, Screening Donated Blood for Transfusion-Transmissible Infections: Recommendations, World Health Organization, Geneva, Switzerland, 2009.
  33. R. N. Makroo, M. Chowdhry, A. Bhatia, B. Arora, and N. L. Rosamma, “Prevalence of HIV among blood donors in a tertiary care centre of north India,” Indian Journal of Medical Research, vol. 134, no. 12, pp. 950–953, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. P. Busch, S. H. Kleinman, B. Jackson, S. L. Stramer, I. Hewlett, and S. Preston, “Committee report. Nucleic acid amplification testing of blood donors fortransfusion-transmitted infectious diseases: report of the interorganizational task force on nucleic acid amplification testing of blood donors,” Transfusion, vol. 40, no. 2, pp. 143–159, 2000. View at Publisher · View at Google Scholar